Render Target: STATIC
Render Timestamp: 2024-11-07T10:39:23.088Z
Commit: 3c1f305a63297e594ac8d7bb5424007d592d68be
XML generation date: 2024-04-24 09:10:48.917
Product last modified at: 2024-06-05T15:45:08.692Z
1% for the planet logo
PDP - Template Name: Chemical Modulators
PDP - Template ID: *******c501c72

Nelfinavir Mesylate #27793

    Product Information

    Product Usage Information

    Nelfinavir Mesylate is supplied as a lyophilized powder. For a 10 mM stock, reconstitute 5 mg of powder in 753 μl of DMSO. Working concentrations and length of treatment can vary depending on the desired effect.

    Storage

    Store lyophilized at -20ºC, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

    Product Description

    Molecular Weight 663.9 g/mol
    Purity >98%
    Molecular Formula C32H45N3O4S • CH3SO3H
    CAS 159989-65-8
    Solubility Soluble in DMSO at 70 mg/ml.

    Background

    Nelfinavir Mesylate, also known as AG-1343, is a potent antiviral inhibitor of HIV-1 protease with a Ki value of 2 nM, in vitro (1). This small molecule is an effective antitumor agent, known to induce endoplasmic reticulum (ER) stress, autophagy, and apoptosis in vitro and in vivo (2). Nelfinavir Mesylate has anti-microbial effects on malaria, tuberculosis, and SARS (3). It has also been used in therapies as an antifibrotic agent against pulmonary fibrosis in patients with systemic sclerosis (4). Nelfinavir Mesylate is known to reduce inflammation by activating protein phosphatase 2 (PP2) and blocking MAPK signaling in macrophages (5). Through a novel mechanism of heat shock protein 90 (HSP90) inhibition, Nelfinavir Mesylate selectively inhibits the growth of HER2-positive breast cancer cells in vitro (6).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.